MEDICAL IP, a company dedicated to medical imaging technology, has been honored with the KAIST President’s Award at the Innovative Startup Awards. This recognition celebrates the company's decade-long commitment to innovation and its founding mission of "Empowering Medicine, Saving Lives." The award serves as a powerful reminder of the company's core values.

From the beginning, MEDICAL IP has sought to transform medical images from simple diagnostic tools into versatile resources for disease prediction, prevention, health management, and education. This approach aims to help not only medical professionals but also the general public to easily understand and manage their own health.

The company offers a suite of advanced solutions, including CT-based body composition analysis solution DeepCatch, X-ray-based quantitative analysis solution DeepCatch X, digital anatomy education solution, MEDIP Box.

The safety and efficacy of these technologies have been validated through certifications from the Korean Ministry of Food and Drug Safety (MFDS) and the U.S. FDA. The company's technical expertise is further supported by over 160 related research papers and academic achievements.

Leveraging this strong foundation, Medical IP is accelerating its market expansion through collaborations with leading domestic and international companies like NVIDIA and DK Medical Systems. Currently, its AI solutions are in use at 52 medical institutions in Korea, including the Korea Association of Health Promotion, and 8 international sites.

Notably, the company is preparing to launch a new product after receiving the world's first Grade 3 medical device approval from the MFDS in March for its AI-powered liver cancer prediction solution.